Proud to share that our portfolio company, Momentis Surgical™, has secured FDA clearance for its next-generation Anovo® robotic system – its second FDA approval in just two weeks! This advanced system brings capabilities previously unseen in #surgical #robotics, including haptic feedback, dual-mode articulation, and unmatched flexibility for both retroflexion and anteflexion within a single incision. These innovations empower physicians with enhanced usability, enabling robotic-assisted procedures that offer human-like dexterity, multi-planar flexibility, and 360-degree articulation. As the Anovo® console remains the only FDA-authorized surgical robotic system, featuring miniature humanoid-shaped robotic arms, Momentis is setting a new standard in robotic #surgery. We’re thrilled to see how Anovo® continues to revolutionize patient care worldwide! #MedicalInnovation, #RoboticSurgery, #HealthcareTech #VentureCapital #Israel
After being in well over 600 robotic surgeries over my career… I really look forward to being in these newly innovated robotic technologies.
This is a great milestone congratulations 👏👏👏
Great to hear. Congrats
Congratulations, Peregrine Ventures and Momentis Surgical™ !
Director of the Valve Center - Direttore della clinica Cardiochirurgica dell’Ospedale San Raffaele- professore ordinario di Cardiochirurgia
1moBring it to cardiac surgery. We can help